Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.

Markar SR. et al, (2023), Br j surg

Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial.

Ross JDC. et al, (2023), Bmc womens health, 23

The DEVA trial: protocol for a randomised controlled trial of dequalinium chloride versus usual care antibiotics for the treatment of bacterial vaginosis.

Haydock R. et al, (2022), Trials, 23

Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.

Armstrong-Buisseret L. et al, (2022), Health technol assess, 26, 1 - 170

POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.

Goyal A. et al, (2021), Bmj open, 11

Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.

Cole MJ. et al, (2020), J antimicrob chemother, 75, 449 - 457

Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.

Armstrong-Buisseret L. et al, (2019), Trials, 20

Measuring patient reported outcomes in the POSNOC trial: strategies employed to promote high quality data return

Monson K. et al, (2019), Trials, 20

Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.

Ross JDC. et al, (2019), Lancet, 393, 2511 - 2520

Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.

Ross JD. et al, (2019), Health technol assess, 23, 1 - 104

Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.

Anstey Watkins J. et al, (2019), Plos one, 14

Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial.

Lim WS. et al, (2017), Trials, 18

THE EFFICACY AND SAFETY OF GENTAMICIN FOR THE TREATMENT OF GENITAL, PHARYNGEAL AND RECTAL GONORRHOEA: A RANDOMISED CONTROLLED TRIAL

Ross JDC. et al, (2017), Sexually transmitted infections, 93, A42 - A43

Mock activation of a pandemic influenza clinical trial: testing for rapid recruitment

Meakin G. et al, (2017), Trials, 18

Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.

Brittain C. et al, (2016), Trials, 17

Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation.

Lim WS. et al, (2015), Health technol assess, 19, 1 - viii

Conducting a randomised trial during an influenza pandemic: an example of a trial set up and ‘hibernated’ ready to activate and recruit within 4 weeks

Brittain C. et al, (2015), Trials, 16, O14 - O14

Randomised trials during a public health crisis, such as pandemic flu: a case study for a model of ‘off the shelf' ready-to-go trials

Whitham D. et al, (2013), Trials, 14